Gadoxetic acid magnetic-enhanced resonance imaging in the diagnosis of cholangiocarcinoma

doi:10.3748/wjg.v26.i29.4261

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7000)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

484

WORD

250

HTML

2995

Figures (1-4)

298

Tables (1-3)

187

Sum=4214

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

365

Download

469

Sum=834

Publishing Process of This Article

Item

Count

Browse

787

Download

1165

Sum=1952

Aug 7, 2020 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 7, 2020; 26(29): 4261-4271
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4261

Table 3 Memorial Sloan Kettering T stage for hilar cholangiocarcinoma

Stage	Criteria
T1	Tumor involving biliary confluence and/or unilateral extension to second-order biliary tracts
T2	T1 and/or ipsilateral portal vein involvement and/or ipsilateral hepatic lobar atrophy
T3	Tumor involving biliary confluence, the biliary extension to second-order biliary tracts; or unilateral extension to second-order biliary tracts with contralateral portal vein involvement; or unilateral extension to second-order radicals with contralateral hepatic lobar atrophy; or main or bilateral portal vein involvement

Citation: Inchingolo R, Maino C, Gatti M, Tricarico E, Nardella M, Grazioli L, Sironi S, Ippolito D, Faletti R. Gadoxetic acid magnetic-enhanced resonance imaging in the diagnosis of cholangiocarcinoma. World J Gastroenterol 2020; 26(29): 4261-4271
URL: https://www.wjgnet.com/1007-9327/full/v26/i29/4261.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i29.4261